Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Nov 16, 2001)

Reports
Other Events
Filing Date
Filed November 16, 2001
Period End
November 16, 2001
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed November 16, 2001. Cited figures are marked; the original filing is the authoritative source.

On November 15, 2001, The Procter & Gamble Company completed its purchase of Bristol-Myers Squibb's Clairol hair care business for $4.95 billiona in cash.

The deal was funded with approximately $500 millionb of existing cash and $4.5 billion of commercial paper issued immediately before closing, which adds significant short-term debt to P&G's balance sheet. The acquired portfolio includes hair colorant brands (Nice 'n Easy, Natural Instincts, Miss Clairol, Hydrience) and hair care brands (Herbal Essences, Aussie, Infusium). The purchase price was set through arm's-length negotiation, and the Stock and Asset Purchase Agreement dated May 20, 2001 was previously filed with the fiscal 2001 Form 10-K.

Strategically, the acquisition moves P&G into the hair colorant category and, per CEO A.G. Lafley, gives it a presence in all major segments of the beauty market. Clairol's roughly $1.6 billionc in annual hair care, hair color and personal care sales is set to be folded into P&G's beauty business, which had about $7.3 billion in global sales in fiscal 2000/01.

Management has said it will spend the next 90 days assessing opportunities before announcing decisions on manufacturing, sourcing, staffing and international offices. It also plans to step up marketing investment and to revive Clairol's position in the professional salon channel.

For investors, the key items are the size of the purchase relative to P&G's scale, the near-term increase in leverage from commercial paper, and the integration risk and cost of the planned marketing push. Future integration plans and any associated cost or synergy figures had not yet been disclosed as of this filing.

Key Highlights

  1. P&G closed the $4.95 billion all-cash acquisition of Clairol from Bristol-Myers Squibb on November 15, 2001, after regulatory clearances worldwide.
  2. Funding was about $500 million from existing cash and $4.5 billion in commercial paper, which increases short-term debt.
  3. Acquired brands include hair colorants (Nice 'n Easy, Miss Clairol, Natural Instincts, Hydrience) and hair care (Herbal Essences, Aussie, Infusium).
  4. The deal gives P&G entry into the hair colorant category and adds Clairol's roughly $1.6 billion in annual hair care, hair color and personal care sales.
  5. Clairol becomes part of P&G's Global Beauty Care unit, with hair color and professional products based in Stamford, CT.
  6. Management plans higher marketing investment and an effort to restore Clairol's leadership in the professional salon channel.
  7. A 90-day review will determine manufacturing, sourcing, staffing and non-U.S. office plans; no synergy or cost figures were disclosed.

Frequently Asked Questions

  1. How was the Clairol acquisition financed?

    The $4.95 billion purchase was funded with roughly $500 million of existing cash and $4.5 billion of debt raised through commercial paper issued just before the closing. The commercial paper component adds short-term borrowings that investors will want to watch as P&G manages its leverage.

  2. What does the acquisition add to P&G's business?

    P&G gains Clairol's hair colorant brands (Nice 'n Easy, Miss Clairol, Natural Instincts, Hydrience) and hair care brands (Herbal Essences, Aussie, Infusium). Clairol's business is described as having about $1.6 billion in annual sales, and P&G says this gives it a presence in every major segment of beauty.

  3. Will there be immediate layoffs or plant closures?

    The filing does not say so. P&G stated that decisions on manufacturing sites, sourcing, staffing and Clairol offices outside the U.S. will be made over the next 90 days, and the company plans a transition period before integrating Clairol's hair care and personal care operations.

  4. Is the purchase price a fair value, and was there any dispute?

    The filing states the $4.95 billion price was set through arm's-length negotiations between P&G and Bristol-Myers Squibb. The full purchase agreement, dated May 20, 2001, was previously filed as an exhibit to P&G's fiscal 2001 Form 10-K.

  5. What are the main near-term catalysts for investors?

    Key items to watch include the 90-day plan on manufacturing, sourcing and staffing, the scale of the step-up in marketing spending, any synergy targets, and progress in reviving Clairol's professional salon business and expanding its brands into new geographies.